ArticleNature biotechnology2018
The Reporting Items for Patent Landscapes statement.
Article in Nature biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Global research on artemisinin and its derivatives: Perspectives from patents.Pharmacological research · 2020Pooled it
- Mapping the TNFR2-targeting antibody patent landscape: Insights from macro trends to structural signatures.Human vaccines & immunotherapeutics · 2026Article
- Exploring the Polyethylene Glycol-Modified Drug Patent Landscape by Deep Learning.Therapeutic innovation & regulatory science · 2026Article
- The global patent landscape of optogenetics: current advances, challenges and opportunities.Nature biotechnology · 2026Article
- Monoclonal antibody formulations: a quantitative analysis of marketed products and patents.mAbs · 2025Article
- Exploring the nanobody patent landscape: a focus on BCMA sequences and structural analysis.mAbs · 2025Article
- Mapping the patent landscape of cancer diagnostics.Nature biotechnology · 2025Article
- PROTAC-PatentDB: A PROTAC Patent Compound Dataset.Scientific data · 2025Article
- Horizon Scanning Methods for Health Care Technology Innovation Identification: Rapid Scoping Review of Patent Research Studies.Interactive journal of medical research · 2025Review
- Mapping the patent landscape of TROP2-targeted biologics through deep learning.Nature biotechnology · 2025Article
- The sufficiency of disclosure of medical artificial intelligence patents.Nature biotechnology · 2024Article
- The global patent landscape of emerging infectious disease monkeypox.BMC infectious diseases · 2024Article
- The global patent landscape of HER2-targeted biologics.Nature biotechnology · 2023Article
- Patent landscape analysis-Contributing to the identification of technology trends and informing research and innovation funding policy.Microbial biotechnology · 2023Article
- Mapping the patent landscape of medical machine learning.Nature biotechnology · 2023Article
- Developments in Leishmaniasis diagnosis: A patent landscape from 2010 to 2022.PLOS global public health · 2023Article
- The global mRNA vaccine patent landscape.Human vaccines & immunotherapeutics · 2022Article
- The worldwide patent landscape of dental implant technology.Biomaterials research · 2022Review
- Delivery of therapeutic small interfering RNA: The current patent-based landscape.Molecular therapy. Nucleic acids · 2022Article
- European patent protection for medical uses of known products and drug repurposing.Nature biotechnology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The reporting quality of patent landscapes is inadequate. The Reporting Items for Patent Landscapes (RIPL) checklist can improve reporting quality.
Indexed as
Identifiers
30412195What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.